Here are 4 biotech stocks that could get a boost from a more open FDA regulatory climate

view original post

Own stocks of companies that get drugs approved. That hasn’t been so easy. But the U.S. Food & Drug Administration (FDA) has become more flexible about granting new drug approvals, and drugs for rare …